114 related articles for article (PubMed ID: 3697936)
61. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
62. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
63. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
Lewandrowski KB; Medeiros LJ; Harris NL
Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
[TBL] [Abstract][Full Text] [Related]
64. Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 cases.
Demurtas A; Stacchini A; Aliberti S; Chiusa L; Chiarle R; Novero D
Cytometry B Clin Cytom; 2013 Mar; 84(2):82-95. PubMed ID: 23325563
[TBL] [Abstract][Full Text] [Related]
65. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
66. [Comparison of three pathologic classifications (Rappaport, LSG and Working Formulation) for the treatment of non-Hodgkin's lymphoma].
Shibuya H; Kamiyama R; Umehara I; Okada Y; Sato S; Yoshimatsu S; Horiuchi J; Suzuki S
Gan No Rinsho; 1985 Nov; 31(14):1757-61. PubMed ID: 4087381
[TBL] [Abstract][Full Text] [Related]
67. The influence of histologic type on survival in early extranodal non-Hodgkin's lymphoma in head and neck.
Aozasa K; Nara H; Ikeda H; Masaki N; Miyata Y; Matsuzuka F; Shigematsu Y
Oncology; 1984; 41(3):164-9. PubMed ID: 6728399
[TBL] [Abstract][Full Text] [Related]
68. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
69. The impact of growth pattern on survival in non-Hodgkin's lymphomas classified according to Lukes and Collins.
Damber L; Lenner P; Lundgren E
Pathol Res Pract; 1982 Jul; 174(1-2):42-52. PubMed ID: 7134063
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S; Bodrug S; Gascoyne R; Berean K; Krajewska M; Reed JC
Am J Pathol; 1994 Sep; 145(3):515-25. PubMed ID: 8080035
[TBL] [Abstract][Full Text] [Related]
71. Non-Hodgkin's lymphomas in the Middle East. A study of 417 patients with emphasis on special features.
Salem P; Anaissie E; Allam C; Geha S; Hashimi L; Ibrahim N; Jabbour J; Habboubi N; Khalyl M
Cancer; 1986 Sep; 58(5):1162-6. PubMed ID: 3731043
[TBL] [Abstract][Full Text] [Related]
72. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
73. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
[TBL] [Abstract][Full Text] [Related]
74. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
75. A morphometric semiautomated method for analyzing cell nuclei in lymph node sections from non-Hodgkin's lymphomas. Significance of data.
Tosi P; Cintorino M; Luzi P; Leoncini L; Spina D
Exp Pathol; 1983; 24(4):237-41. PubMed ID: 6686963
[TBL] [Abstract][Full Text] [Related]
76. Stereological analysis of non-Hodgkins lymphomas.
Zardawi IM; Firman DW; Sims TA
Pathology; 1984 Oct; 16(4):387-92. PubMed ID: 6522103
[TBL] [Abstract][Full Text] [Related]
77. Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma.
Mazur G; Jaskuła E; Kryczek I; Dłubek D; Butrym A; Wróbel T; Lange A; Kuliczkowski K
Folia Histochem Cytobiol; 2011; 49(2):240-7. PubMed ID: 21744323
[TBL] [Abstract][Full Text] [Related]
78. [Cell proliferation indicators in malignant non-Hodgkin's lymphoma].
Urasiński I; Kordecki H
Nowotwory; 1982; 32(4):227-33. PubMed ID: 7186121
[No Abstract] [Full Text] [Related]
79. Prognostic significance of architectural patterns in non-Hodgkin lymphomas.
Schultz HB; Ersbøll J; Hougaard P
Scand J Haematol; 1985 Sep; 35(3):270-83. PubMed ID: 4059857
[TBL] [Abstract][Full Text] [Related]
80. A retrospective clinico-pathologic study of non-Hodgkin's lymphomas classified according to the nomenclatures of Lennert and of Rappaport.
Cavallin-Ståhl E; Landberg T; Lindberg LG; Akerman M
Acta Med Scand; 1981; 209(5):407-14. PubMed ID: 7246275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
